Organ Preservation Market: Market Size & Forecast 2026

The organ preservation market includes preservation solutions, perfusion devices, and related equipment designed to protect organs from ischemic damage during the critical period between retrieval and implantation. Static cold storage remains the most widely used technique, though machine perfusion is gaining traction for extending preservation windows and improving organ quality. The sector serves hospitals, transplant centers, and organ procurement organizations globally, with products covering kidneys, livers, hearts, lungs, and other vital organs.

• •Market valued at approximately $268 million globally in 2025
• •Projected to reach around $300 million by 2030 based on current growth trajectories
• •Encompasses preservation solutions, hypothermic and normothermic perfusion machines, and related accessories

Rising incidence of chronic organ failure diseases, including chronic kidney disease, liver cirrhosis, and heart failure, has increased demand for transplant procedures and subsequently preservation solutions. Improvements in immunosuppressive therapies and surgical techniques have expanded the pool of eligible transplant recipients, further stimulating market demand. Government initiatives promoting organ donation and establishing national registries in various countries have also contributed to higher procurement rates and market expansion.

• •Increasing prevalence of end-stage organ disease driving transplant volume growth
• •Technological advances in machine perfusion extending viable preservation periods
• •Growing awareness campaigns and policy support for organ donation programs

The market is segmented by solution type, including preservation solutions such as UW solution and HTK solution, and by technique, primarily static cold storage versus dynamic machine perfusion. North America dominates the market due to advanced healthcare infrastructure, high transplant volumes, and favorable reimbursement policies, while Europe follows closely with established transplant networks. The Asia-Pacific region is projected to witness the fastest growth, fueled by increasing healthcare investment, rising organ failure rates, and expanding transplant programs in countries like China, India, and Japan.

• •North America holds the largest regional share with established transplant infrastructure
• •Asia-Pacific is the fastest-growing region driven by improving healthcare access and rising disease prevalence
• •Machine perfusion segment is expanding as evidence mounts for improved organ viability and reduced rejection rates

What are the recent trends and outlook?

The organ preservation market is moving toward normothermic perfusion technologies that maintain organs at body temperature, potentially improving outcomes compared to traditional hypothermic methods. Research into ex vivo organ conditioning and gene-editing applications for preservation solutions may further transform the sector over the coming decade. Emerging markets in Latin America and the Middle East are expected to present growth opportunities as healthcare systems develop and transplant capabilities expand.

• •Normothermic machine perfusion gaining clinical adoption for hearts and lungs, with expansion into liver and kidney applications
• •Integration of artificial intelligence and sensors for real-time organ viability monitoring during preservation
• •Growing trend toward portable and compact perfusion devices facilitating wider geographic organ sharing